AG/GHSR1a axis has been proposed as a promising therapeutic target in a variety of metabolic disorders due to its pleiotropic effects on appetite, energy metabolism, glucose homeostasis, and GH release. This evidence concerns the gene RENBP and Other metabolic disease.